ReviewProgress in neuro-psychopharmacology & biological psychiatry2015

Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end?

Meng-Lin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.